ALL WE DO IS TREAT PROSTATE CANCER - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
85160644
Word Mark
ALL WE DO IS TREAT PROSTATE CANCER
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2011-08-31
Filing Date
2010-10-25
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
L60
Employee Name
SINGH, TEJBIR
Statements
Goods and Services
prostate cancer treatment
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2010-10-28
Primary Code
005
First Use Anywhere Date
2010-06-01
First Use In Commerce Date
2010-10-21
Correspondences
Name
KATHLEEN A. KRESS, ESQ.
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2010-10-28 | NEW APPLICATION ENTERED IN TRAM |
2010-10-28 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2010-11-19 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2010-11-19 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2010-11-19 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
2010-11-19 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
2011-02-02 | ASSIGNED TO EXAMINER |
2011-02-02 | NON-FINAL ACTION WRITTEN |
2011-02-02 | NON-FINAL ACTION E-MAILED |
2011-02-02 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2011-08-31 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2011-08-31 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |